ONCOSPIRE CONSULTANTS
Live / Registered — Registered (as of 03 Feb 2026)
What this means for you
Registered since 03 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98443088
- Registration number
- 8129310
- Mark type
- Stylized text
- Filed
- 11 Mar 2024
- Published for opposition
- 05 Nov 2024
- Registered
- 03 Feb 2026
- Attorney of record
- Paul Martello
Goods and services
- Class 035 — Advertising and business services: Business consulting services in the field of project management, Food and Drug Administration compliance, New Drug Applications (NDA), and clinical operations for the oncology and life sciences industries; Business management consulting, strategic planning and business advisory services provided to oncology and life sciences industries; Professional business consulting
- Class 041 — Education and entertainment services: Education services, namely, providing classes, seminars, workshops in the field of project management, Food and Drug Administration compliance, New Drug Applications (NDA), clinical operations, leadership, career progression, the oncology and life sciences industries; Entertainment services, namely, providing podcasts in the field of project management, Food and Drug Administration compliance, New Drug Applications (NDA), clinical operations, leadership, career progression, the oncology and life sciences industries; On-line journals, namely, blogs featuring information in the fields of project management, Food and Drug Administration compliance, New Drug Applications (NDA), clinical operations, leadership, career progression, the oncology and life sciences industries; Providing educational mentoring services and programs in the field of project management, Food and Drug Administration compliance, New Drug Applications (NDA), clinical operations, leadership, career progression, the oncology and life sciences industries; Providing on-line videos featuring information in the fields of project management, Food and Drug Administration compliance, New Drug Applications (NDA), clinical operations, leadership, career progression, the oncology and life sciences industries, not downloadable
Owner
- Oncospire Consultants LLC, Hatfield, PA, US
- Oncospire Consultants LLC, Hatfield, PA, US
- Oncospire Consultants LLC, Hatfield, PA, US
Prosecution history
- 03 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 03 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 15 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Dec 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Jun 2025 — USE AMENDMENT FILED
- 08 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 17 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Nov 2024 — PUBLISHED FOR OPPOSITION
- 16 Oct 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Sept 2024 — EXAMINER'S AMENDMENT ENTERED
- 26 Sept 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED